Active (not recruiting) Phase 1 2025-523686-15-00

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Phase 1 – testing safety in a small group of people

Conditions: Advanced or Metastatic Solid Tumors

Sponsor: Olema Pharmaceuticals Inc.

trial.available_in:

БГ

Overview

Trial status: Authorised

Who can participate

Age group: 18-64 years, 65+ years Gender: Female, Male Target enrollment: 48 participants

France (1)

Ireland (1)

Spain (1)

Status

Active (not recruiting)

Phase

Phase 1

Study type

INTERVENTIONAL

Sex

Male and female

Minimum age

18 Years

Healthy volunteers

Start date

17.03.2026

Registry ID

2025-523686-15-00

Source

euclinicaltrials.eu

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.